Dymon Asia Capital (Singapore)’s BioNTech BNTX Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Sell	20,000 -1,000	-5%	-$94.1K	0.08%	133
2026 Q1	$1.87M	Buy	21,000 +15,000	+250%	+$1.54M	0.19%	132
2025 Q4	$571K	Sell	6,000 -4,000	-40%	-$403K	0.06%	191
2025 Q3	$986K	Sell	10,000 -7,500	-43%	-$802K	0.1%	180
2025 Q2	$1.86M	Buy	+17,500	New	+$1.77M	0.26%	78

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Dymon Asia Capital (Singapore)'s BNTX Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) reduced its BioNTech (BNTX) stake by 4.8% in Q2 2026, selling an estimated $94.1K and leaving 20,000 shares worth $1.86M. The position accounts for 0.08% of the portfolio, ranked #133.

Dymon Asia Capital (Singapore) first reported a position in BNTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.87M in Q1 2026. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Dymon Asia Capital (Singapore) held 20,000 shares of BioNTech worth $1.86M as of Q2 2026.
Dymon Asia Capital (Singapore) sold 1,000 BioNTech shares in Q2 2026, an estimated $94.1K.
BioNTech made up 0.08% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #133 holding.
Dymon Asia Capital (Singapore) first reported a position in BioNTech in Q2 2025 and has held it in 5 quarters since.
Dymon Asia Capital (Singapore)'s BioNTech position peaked at $1.87M in Q1 2026.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.